MedTrace Logo

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

NCT06425848 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-05-22

No results posted yet for this study

Summary

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

Conditions

Interventions

DEVICE

Observational

We are collecting information for both retrospective and prospective arm to further understand the utility of PA pressure sensors.

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Hirak Shah, MD · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-21
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425848 on ClinicalTrials.gov